Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.7 HKD | +2.33% | +9.44% | +20.14% |
01/05 | Henlius Biotech Logs 1.35 Billion Yuan Revenue in Q1 | MT |
26/04 | Shanghai Henlius Biotech's Cancer Drug Gets the Nod from US FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.14% | 1.13B | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-17.49% | 31.47B | |
+54.44% | 25.24B | |
-13.13% | 15.82B | |
-9.12% | 11.96B | |
-15.45% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B |
- Stock Market
- Equities
- 2696 Stock
- News Shanghai Henlius Biotech, Inc.
- Shanghai Henlius Biotech : Wins Nod to Add Second Factory for Cancer Treatment in China; Shares Slump 8%